Healthcare
2 evidence matches
Impact 99% Confidence 90%
Health
National Clinical Care Commission Act Became Public Law No: 115-80. Health
S 920 - 115National Clinical Care Commission Act
Became Public Law No: 115-80.
Bill Text Stats
Bill text analysis is not available for this record yet.
Affected Sectors
How to read this
Sectors are deterministic matches from official Congress.gov data and cached bill text. They are source-derived signals, not conclusions about intent or economic effect.
Evidence matches count official fields, normalized subjects, cached text snippets, or extracted entities that matched the sector rules.
Impact is a bill-level rollup used for sorting and filtering. It is not an economic impact estimate.
Confidence is the strongest individual match score behind that sector.
Evidence snippets show why a sector matched and can repeat when Congress.gov repeats the same phrase across official fields.
CBO Cost Estimates
Official Congressional Budget Office cost estimate links associated with this bill through Congress.gov records.
How to read this
CBO estimates are official source documents with their own assumptions, scope, and publication dates. They can score a bill, a version of a bill, or a broader legislative package.
LawLinter stores the source link from Congress.gov and does not replace the CBO document. Use these cards as pointers for source review, not as independent fiscal advice.
CBO context shows source-attributed Congressional Budget Office cost estimates linked from official Congress.gov bill records. It is research context only; read the official CBO source document for assumptions, scope, and dates.
Campaign Finance Context
Related FEC/OpenFEC campaign-finance records for lawmakers and candidates tied to this bill through source-attributed legislative relationships. These are not donations to the bill itself.
How to read this
Amounts shown here are campaign-finance totals for sponsor or cosponsor-linked candidates and their committees in the displayed FEC cycle.
They are not donations to this bill, spending on this bill, or proof that money influenced or caused sponsorship, cosponsorship, votes, or legislative outcomes.
If multiple linked lawmakers have FEC records, this section can show multiple candidate cards and separate sponsor/cosponsor rollups.
Campaign-finance context uses source-attributed FEC/OpenFEC records that are related or relevant to the displayed bill, lawmaker, candidate, committee, or legislative relationship through deterministic links. It is research context only, not proof of influence, causation, endorsement, or that money caused a sponsorship, vote, or legislative outcome.
No FEC/OpenFEC campaign-finance context is currently linked for this bill.
Lobbying Context
Related LDA.gov filings where public lobbying activity descriptions reference this bill. These records are source-attributed research context, not evidence of influence or causation.
How to read this
LDA filings are public lobbying disclosure records. LawLinter links them here only when the filing activity text contains an exact-looking reference to this bill.
A filing can mention many issues, clients, agencies, or bills. A match should be treated as a pointer for review, not as a conclusion about why legislation changed or how any lawmaker acted.
Lobbying context uses source-attributed LDA.gov records that appear related to this bill through bill references in public lobbying activity descriptions. It is research context only, not proof of influence, causation, endorsement, lobbying effectiveness, or legislative intent.
No LDA.gov lobbying disclosure context is currently linked for this bill.
Summary
81 Passed House without amendment Jan 17, 2018
(This measure has not been amended since it was passed by the Senate on September 6, 2017. The summary of that version is repeated here.) National Clinical Care Commission Act (Sec. 2) This bill establishes within the Department of Health and Human Services (HHS) a National Clinical Care Commission to evaluate and make recommendations regarding improvements to the coordination and leveraging of federal programs related to complex metabolic or autoimmune diseases that result from issues related to insulin and represent a significant disease burden (e.g., diabetes). The commission must report on: (1) HHS programs that focus on prevention, (2) current activities and gaps in federal efforts to support clinicians in providing integrated care, (3) improvement in federal education and awareness activities related to prevention and treatment, (4) methods for outreach and dissemination of education and awareness materials, and (5) opportunities for consolidation of overlapping federal programs. The commission must submit an operating plan to HHS and Congress within 90 days of its first meeting. The commission is terminated after it submits a final report, but not later than the end of FY2021.
00 Introduced in Senate Jan 17, 2018
National Clinical Care Commission Act This bill establishes within the Department of Health and Human Services (HHS) a National Clinical Care Commission to evaluate and make recommendations regarding improvements to the coordination and leveraging of federal programs related to complex metabolic or autoimmune diseases that result from issues related to insulin and represent a significant disease burden (e.g., diabetes). The commission must report on: (1) HHS programs that focus on prevention, (2) current activities and gaps in federal efforts to support clinicians in providing integrated care, (3) improvement in federal education and awareness activities related to prevention and treatment, and (4) methods for outreach and dissemination of education and awareness materials. The commission must submit an operating plan to HHS and Congress within 90 days of its first meeting. The commission is terminated after it submits a final report, but not later than the end of FY2021.
49 Public Law Dec 28, 2017
(This measure has not been amended since it was passed by the Senate on September 6, 2017. The summary of that version is repeated here.) National Clinical Care Commission Act (Sec. 2) This bill establishes within the Department of Health and Human Services (HHS) a National Clinical Care Commission to evaluate and make recommendations regarding improvements to the coordination and leveraging of federal programs related to complex metabolic or autoimmune diseases that result from issues related to insulin and represent a significant disease burden (e.g., diabetes). The commission must report on: (1) HHS programs that focus on prevention, (2) current activities and gaps in federal efforts to support clinicians in providing integrated care, (3) improvement in federal education and awareness activities related to prevention and treatment, (4) methods for outreach and dissemination of education and awareness materials, and (5) opportunities for consolidation of overlapping federal programs. The commission must submit an operating plan to HHS and Congress within 90 days of its first meeting. The commission is terminated after it submits a final report, but not later than the end of FY2021.
35 Passed Senate amended Sep 25, 2017
National Clinical Care Commission Act (Sec. 2) This bill establishes within the Department of Health and Human Services (HHS) a National Clinical Care Commission to evaluate and make recommendations regarding improvements to the coordination and leveraging of federal programs related to complex metabolic or autoimmune diseases that result from issues related to insulin and represent a significant disease burden (e.g., diabetes). The commission must report on: (1) HHS programs that focus on prevention, (2) current activities and gaps in federal efforts to support clinicians in providing integrated care, (3) improvement in federal education and awareness activities related to prevention and treatment, (4) methods for outreach and dissemination of education and awareness materials, and (5) opportunities for consolidation of overlapping federal programs. The commission must submit an operating plan to HHS and Congress within 90 days of its first meeting. The commission is terminated after it submits a final report, but not later than the end of FY2021.
80 Reported to Senate without amendment Jul 17, 2017
(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.) National Clinical Care Commission Act (Sec. 2) This bill establishes within the Department of Health and Human Services (HHS) a National Clinical Care Commission to evaluate and make recommendations regarding improvements to the coordination and leveraging of federal programs related to complex metabolic or autoimmune diseases that result from issues related to insulin and represent a significant disease burden (e.g., diabetes). The commission must report on: (1) HHS programs that focus on prevention, (2) current activities and gaps in federal efforts to support clinicians in providing integrated care, (3) improvement in federal education and awareness activities related to prevention and treatment, and (4) methods for outreach and dissemination of education and awareness materials. The commission must submit an operating plan to HHS and Congress within 90 days of its first meeting. The commission is terminated after it submits a final report, but not later than the end of FY2021.
Sponsors
Website
N/A
Phone
N/A
Office
N/A
Timeline
Nov 2, 2017
Signed by President.
Nov 2, 2017
Signed by President.
Nov 2, 2017
Became Public Law No: 115-80.
Nov 2, 2017
Became Public Law No: 115-80.
Oct 24, 2017
Presented to President.
Oct 24, 2017
Presented to President.
Oct 11, 2017
Mr. Olson moved to suspend the rules and pass the bill.
Oct 11, 2017
Considered under suspension of the rules. (consideration: CR H7946-7948)
Oct 11, 2017
DEBATE - The House proceeded with forty minutes of debate on S. 920.
Oct 11, 2017
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H7946)
Oct 11, 2017
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H7946)
Oct 11, 2017
Motion to reconsider laid on the table Agreed to without objection.
Sep 7, 2017
Message on Senate action sent to the House.
Sep 7, 2017
Received in the House.
Sep 7, 2017
Held at the desk.
Sep 6, 2017
Measure laid before Senate by unanimous consent. (consideration: CR S5019-5020)
Sep 6, 2017
Passed/agreed to in Senate: Passed Senate with amendments by Unanimous Consent.(text: CR S5019-5020)
Sep 6, 2017
Passed Senate with amendments by Unanimous Consent. (text: CR S5019-5020)
May 1, 2017
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander without amendment. Without written report.
May 1, 2017
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander without amendment. Without written report.
May 1, 2017
Placed on Senate Legislative Calendar under General Orders. Calendar No. 47.
Apr 26, 2017
Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.
Apr 24, 2017
Introduced in Senate
Apr 24, 2017
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
House Votes
No House roll call votes have been linked to this bill yet.
Amendments
No amendment records are currently available for this bill.
Compiled bill record. Bill pages combine Congress.gov source payloads, normalized relationships, cached text analysis, vote links, and deterministic sector/signal extraction. This is not an official government record or legal advice; use the official source link when accuracy matters.